Corcept Therapeutics GAAP EPS de $ 1,01 batimentos por $ 0,22, receita de US$ 340,5 milhões batimentos por US$ 4,12 milh

Corcept Therapeutics Q3 earnings beat estimates on EPS and revenue, with strong profit growth and cash gains.